SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130 - PubMed (original) (raw)
. 2000 Apr 28;275(17):12848-56.
doi: 10.1074/jbc.275.17.12848.
Affiliations
- PMID: 10777583
- DOI: 10.1074/jbc.275.17.12848
Free article
SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130
J Schmitz et al. J Biol Chem. 2000.
Free article
Abstract
Interleukin-6 is involved in the regulation of many biological activities such as gene expression, cell proliferation, and differentiation. The control of the termination of cytokine signaling is as important as the regulation of initiation of signal transduction pathways. Three families of proteins involved in the down-regulation of cytokine signaling have been described recently: (i) SH2 domain-containing protein-tyrosine phosphatases (SHP), (ii) suppressors of cytokine signaling (SOCS), and (iii) protein inhibitors of activated STATs (PIAS). We have analyzed the interplay of two inhibitors in the signal transduction pathway of interleukin-6 and demonstrate that the tyrosine phosphatase SHP2 and SOCS3 do not act independently but are functionally linked. The activation of one inhibitor modulates the activity of the other; Inhibition of SHP2 activation leads to increased SOCS3-mRNA levels, whereas increased expression of SOCS3 results in a reduction of SHP2 phosphorylation after activation of the interleukin-6 signal transduction pathway. Furthermore, we show that tyrosine 759 in gp130 is essential for both SHP2 and SOCS3 but not for SOCS1 to exert their inhibitory activities on interleukin-6 signal transduction. Besides SHP2, SOCS3 also interacts with the Tyr(P)-759 peptide of gp130. Taken together, our results suggest differences in the function of SOCS1 and SOCS3 and a link between SHP2 and SOCS3.
Similar articles
- Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2.
Fairlie WD, De Souza D, Nicola NA, Baca M. Fairlie WD, et al. Biochem J. 2003 Jun 1;372(Pt 2):495-502. doi: 10.1042/BJ20030104. Biochem J. 2003. PMID: 12593670 Free PMC article. - SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
Lehmann U, Schmitz J, Weissenbach M, Sobota RM, Hortner M, Friederichs K, Behrmann I, Tsiaris W, Sasaki A, Schneider-Mergener J, Yoshimura A, Neel BG, Heinrich PC, Schaper F. Lehmann U, et al. J Biol Chem. 2003 Jan 3;278(1):661-71. doi: 10.1074/jbc.M210552200. Epub 2002 Oct 27. J Biol Chem. 2003. PMID: 12403768 - TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
Bode JG, Schweigart J, Kehrmann J, Ehlting C, Schaper F, Heinrich PC, Häussinger D. Bode JG, et al. J Immunol. 2003 Jul 1;171(1):257-66. doi: 10.4049/jimmunol.171.1.257. J Immunol. 2003. PMID: 12817006 - Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L. Heinrich PC, et al. Biochem J. 1998 Sep 1;334 ( Pt 2)(Pt 2):297-314. doi: 10.1042/bj3340297. Biochem J. 1998. PMID: 9716487 Free PMC article. Review. - Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: regulators of B cell signal transduction.
Tamir I, Dal Porto JM, Cambier JC. Tamir I, et al. Curr Opin Immunol. 2000 Jun;12(3):307-15. doi: 10.1016/s0952-7915(00)00092-3. Curr Opin Immunol. 2000. PMID: 10781410 Review.
Cited by
- The Spatiotemporal Expression of SOCS3 in the Brainstem and Spinal Cord of Amyotrophic Lateral Sclerosis Mice.
Lin CY, Vanoverbeke V, Trent D, Willey K, Lee YS. Lin CY, et al. Brain Sci. 2024 May 31;14(6):564. doi: 10.3390/brainsci14060564. Brain Sci. 2024. PMID: 38928564 Free PMC article. - Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis.
Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, Miyoshi K, Komiya S, Kosai K, Hanakawa Y, Hashimoto K, Nagata K, Yoshimura A. Shouda T, et al. J Clin Invest. 2001 Dec;108(12):1781-8. doi: 10.1172/JCI13568. J Clin Invest. 2001. PMID: 11748261 Free PMC article. - Interpreting mixed signals: the cell's cytokine conundrum.
Delgoffe GM, Murray PJ, Vignali DA. Delgoffe GM, et al. Curr Opin Immunol. 2011 Oct;23(5):632-8. doi: 10.1016/j.coi.2011.07.013. Epub 2011 Aug 16. Curr Opin Immunol. 2011. PMID: 21852079 Free PMC article. Review. - IL-6 in inflammation, immunity, and disease.
Tanaka T, Narazaki M, Kishimoto T. Tanaka T, et al. Cold Spring Harb Perspect Biol. 2014 Sep 4;6(10):a016295. doi: 10.1101/cshperspect.a016295. Cold Spring Harb Perspect Biol. 2014. PMID: 25190079 Free PMC article. Review. - Interleukin (IL-6) Immunotherapy.
Tanaka T, Narazaki M, Kishimoto T. Tanaka T, et al. Cold Spring Harb Perspect Biol. 2018 Aug 1;10(8):a028456. doi: 10.1101/cshperspect.a028456. Cold Spring Harb Perspect Biol. 2018. PMID: 28778870 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous